{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:08:44Z","timestamp":1791889724937,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ajog.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T10:49:35Z","timestamp":1528454975000},"page":"275.e1-275.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage"],"prefix":"10.1016","volume":"219","author":[{"given":"De-Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette R.","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Odouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.06.002_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pds.3495","article-title":"Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk","volume":"22","author":"Thorpe","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2018.06.002_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/REP-15-0496","article-title":"Prostaglandin F2alpha promotes angiogenesis and embryo-maternal interactions during implantation","volume":"151","author":"Kaczynski","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0002-9378(93)90292-Q","article-title":"Nonsteroidal antiinflammatory drugs and reproduction","volume":"169","author":"Dawood","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.06.002_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.humrep.a137354","article-title":"Influence of prostaglandins and platelet activating factor on implantation","volume":"6","author":"Van der Weiden","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/rheumatology\/36.5.605a","article-title":"Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption","volume":"36","author":"Van der Weiden","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ajog.2018.06.002_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.06.002_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2018.06.002_bib9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1526-4610.2012.02172.x","article-title":"Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes","volume":"52","author":"Berard","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.ajog.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1503\/cmaj.130605","article-title":"Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions","volume":"186","author":"Daniel","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2018.06.002_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0b013e3182595671","article-title":"Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion","volume":"120","author":"Velez Edwards","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.06.002_bib12","first-page":"103","article-title":"Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study","volume":"32","author":"McInerney","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2018.06.002_bib13","first-page":"1100","article-title":"Cox\u2019s regression model for counting processes: a large sample study","volume":"10","author":"Anderson","year":"1982","journal-title":"Ann Stat"},{"key":"10.1016\/j.ajog.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/aje\/kwk027","article-title":"Conditions for bias from differential left truncation","volume":"165","author":"Howards","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2018.06.002_bib15","series-title":"Modeling survival data: extending the Cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.ajog.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.1203369","article-title":"Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production","volume":"191","author":"Hellmann","year":"2013","journal-title":"J\u00a0Immunol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:19:33Z","timestamp":1757589573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818304897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002937818304897"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.06.002","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}